NCT05519111 Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain Status RECRUITING Phase PHASE2
NCT05506358 Evaluation of Low-cost Techniques for Detecting Sickle Cell Disease and β-thalassemia in Nepal and Canada Status COMPLETED Phase NA
NCT05477563 Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease Status RECRUITING Phase PHASE3
NCT05470998 L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity Status COMPLETED Phase PHASE3
NCT05470270 Acceptability of a New Paediatric Formulation of Hydroxycarbamide in Children With Sickle Cell Disease. Status COMPLETED Phase PHASE2
NCT05469828 Crizanlizumab Improves Tissue Oxygen Supply Demand Matching in Patients With Sickle Cell Anemia Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT05457790 Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD) Status SUSPENDED Phase NA
NCT05456880 BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05445128 Study of MGTA-145 and Plerixafor in Patients With Sickle Cell Disease Status TERMINATED Phase PHASE2
NCT05434000 Primary Prevention of Stroke in Children With Sickle Cell Anaemia in Nigeria in the Community Status UNKNOWN Phase NA
NCT05431088 A Phase 2/3 Study in Adult and Adolescent Participants With SCD Status RECRUITING Phase PHASE2/PHASE3
NCT05405114 Research Study Investigating How Well NDec Works in People With Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT05392894 RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease Status RECRUITING Phase PHASE3
NCT05392101 Low Dose Iron Chelation as TReatment of Oxidative Damage in Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT05389891 Hemoglobinopathy Nursing Program and Pediatric Nursing Students Status COMPLETED Phase NA
NCT05384756 TMLI and Alemtuzumab for Treatment of Sickle Cell Disease Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05383911 Empowering Adolescents and Young Adults With Sickle Cell Disease as Partners in Treatment Decision Making (EMPOWER-AYA) Status RECRUITING Phase NA